High dose pimozide does not block amphetamine-induced euphoria in normal volunteers

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 2, 1997, Pages 265-272

  Brauer, Lisa H ^a,b   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

amphetamine; antagonism; dopamine; dopamine antagonists; drug interaction; drug mechanism; euphoria; neuroleptics; normal volunteers; subjective effects

Indexed keywords

AMPHETAMINE; NEUROLEPTIC AGENT; PIMOZIDE;

ADULT; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; EUPHORIA; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; DEXTROAMPHETAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EUPHORIA; FEMALE; HUMANS; MALE; PIMOZIDE;

EID: 0031055996     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00240-7     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd ed., Revised ). Washington DC: American Psychiatric Association; 1987.
2. Anden, N.; Butcher, S.; Corrodi, H.; Fuxe, K.; Ungerstedt, U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 11:303-314; 1970.
3. Angrist, B.; Corwin, J.; Bartlik, B.; Cooper, T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol. Psychiatry 22:1357-1368; 1987.
4. Arnt, J. Inhibitory effects on the discriminative stimulus properties of d-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system? Psychopharmacology 124:117-125; 1996.
5. Brauer, L.; Ambre, J.; de Wit, H. Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy volunteers. J. Clin. Psychopharmacol. 16:72-76; 1996.
6. Brauer, L.; de Wit, H. Role of dopamine in d-amphetamine-induced euphoria. Experimental and Clinical Psychopharmacology 3:1995.
7. Brauer, L.; de Wit, H. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol. Psychiatry 39:26-32; 1996.
8. Colpaert, F.; Niemegeers, C.; Janssen, P. Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol: A comparative study. Neuropharmacology 17:937-942; 1978.
9. Farde, L.; Nordstrom, A.; Wiesel, F.; Pauli, S.; Halldin, C.; Sedvall, G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch. Gen. Psychiatry 49:538-544; 1992.
10. Fischman, M. Relationship between self-reported drug effects and their reinforcing effects: Studies with stimulant drugs. In: Fischman, M.; Mello, N., eds. Testing for abuse liability of drugs in humans. Washington, DC: US Government Printing Office;1989:211-230.
11. Fischman, M.; Foltin, R. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br. J. Addict. 86:1563-1570; 1991.
12. Foltin, R.; Fischman, M. Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug Alcohol Depend. 28:3-48; 1991.
13. Goudie, A. Discriminative stimulus properties of amphetamine, cathinone, and related agents. In Glennon, R. A.;Jarbe, T. U. C.; Frankenheim, J., eds. Drug discrimination: Applications to drug abuse research. Washington DC: U.S. Government Printing Office;1991:45-60.
14. Gunne, L.; Anggard, E.; Jonsson, L. Clinical trials with amphetamine-blocking drugs. Psychiatr. Neurol. Neurochirugia 75:225-226; 1972.
15. Haertzen, C.; Hill, H.; Belleville, R. Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacology 4:155-166; 1963.
16. Hindmarch, I.; Kerr, J.; Sherwood, N. The effects of alcohol and other drugs on psychomotor performance and cognitive function. Alcohol Alcoholism 26:71-79; 1991.
17. Hyttel, J.; Larsen, J.; Christensen, A.; Arnt, J. Receptor-binding profiles of neuroleptics. Psychopharmacology Supplementum 2:9-18; 1985.
18. Jacobs, D.; Silverstone, T. Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychol. Med. 16:323-329; 1986.
19. Johanson, C.; Kilgore, K.; Uhlenhuth, E. Assessment of dependence potential of drugs using multiple indices. Psychopharmacology 81:1983.
20. Johanson, C.; Uhlenhuth, E. Drug preference and mood in humans: d-amphetamine. Psychopharmacology 71:275-279; 1980.
21. Jonsson, L. Pharmacological blockade of amphetamine effects in amphetamine dependent subjects. Eur. J. Clin. Pharmacol. 4:206-211; 1972.
22. Kamien, J.; Woolverton, W. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J. Pharmacol. Exper. Ther. 248:938-946; 1989.
23. Keppel, G. Design and analysis: A researcher's handbook. (2nd ed.). Englewood Cliffs, NJ: Prentice-Hall, Inc.; 1982.
24. Lamb, R.; Preston, K.; Schindler, C.; Meisch, R.; Davis, F.; Katz, J.; Henningfield, J.; Goldberg, S. The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. J. Pharmacol. Exper. Ther. 259:1165-1173; 1991.
25. Martin, W.; Sloan, J.; Sapira, J.; Jasinski, D. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12:245-258; 1971.
26. McMillen, B.; Geman, D.; Sanghera, M.; Warnack, W.; Shore, P. Pimozide: Delayed onset of action at rat striatal pre- and postsynaptic receptors. J. Pharmacol. Exper. Ther. 215:150-155; 1980.
27. McNair, D.; Lorr, M.; Droppleman, L. Profile of Mood States (Manual). San Francisco: Educational and Industrial Testing Service; 1971.
28. Nielsen, E.; Jepsen, S. Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. Eur. J. Pharmacol. 11:167-176; 1985.
29. Nuotto, E.; Kortilla, K. Evaluation of a new psychomotor test battery: Effects of alcohol. Pharmacol. Toxicol. 68:360-365; 1991.
30. Nurnberger, J.; Simmons-Alling, S.; Kessler, L.; Jimerson, S.; Schreiber, J.; Hollander, E.; Tamminga, C.; Nadi, N.; Goldstein, D.; Gershon, E. Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man. Psychopharmacology 84:200-204; 1984.
31. Pinder, R.; Brogden, R.; Sawyer, P.; Speight, T.; Spencer, R.; Avery, G. Pimozide: A review of its pharmacological properties and therapeutic uses in psychiatry. Drugs 12:1-40; 1976.
32. Risner, M.; Jones, B. Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacol. Biochem. Behav. 5:477-482; 1976.
33. Robinson, T.; Berridge, K. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18:247-291; 1993.
34. Schechter, M.; Cook, P. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats. Psychopharmacology 42:185-193; 1975.
35. Seiden, L.; Sabol, K.; Ricuarte, G. Amphetamine: Effects on catecholamine systems and behavior. Ann. Rev. Pharmacol. Toxicol. 32:639-377; 1993.
36. Silverstone, T.; Fincham, J.; Wells, B.; Kyriakides, M. The effect of the dopamine receptor blocking drugpimozide on the stimulant and anorectic actions of dextroamphetamine in man. Neuropharmacology 19:1235-1237; 1980.
37. Tella, S. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48:151-159; 1994.
38. Wechsler, D. The Measure and Appraisal of Adult Intelligence. (4th ed.). Baltimore: Williams & Wilkins; 1958.
39. Woolverton, W. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24:531-535; 1986.
40. Woolverton, W.; Kamien, J.; Kleven, M. Blockade of the discriminative stimulus effects of cocaine and d-amphetamine in rhesus monkeys with the D1 dopamine antagonist SCH 23390. Pharmacologist 29:158; 1987.
41. Yokel, R.; Wise, R. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science 187:547-549; 1975.
42. Yokel, R.; Wise, R. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311-318; 1976.